These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 11479215

  • 1. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
    Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH.
    Cancer Res; 2001 Aug 01; 61(15):5778-83. PubMed ID: 11479215
    [Abstract] [Full Text] [Related]

  • 2. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A, O'Brien KP, Sjöblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A.
    Cancer Res; 1999 Aug 01; 59(15):3719-23. PubMed ID: 10446987
    [Abstract] [Full Text] [Related]

  • 3. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS, Zamolyi R, Franco MF, Nascimento AG, Abott JJ, Wang X, Erickson-Johnson MR, Oliveira AM.
    Genes Chromosomes Cancer; 2008 Mar 01; 47(3):260-5. PubMed ID: 18069662
    [Abstract] [Full Text] [Related]

  • 4. Detection of COL1A1-PDGFB fusion transcripts and platelet-derived growth factor alpha and beta receptors in giant cell fibroblastoma of the postsacrococcygeal region.
    Kashima A, Yamashita A, Moriguchi S, Marutsuka K, Tsumori S, Yoshizato K, Ishihara A, Setoyama M, Asada Y.
    Br J Dermatol; 2006 May 01; 154(5):983-7. PubMed ID: 16634907
    [Abstract] [Full Text] [Related]

  • 5. Dermatofibrosarcoma protuberans: increased growth response to platelet-derived growth factor BB in cell culture.
    Kikuchi K, Soma Y, Fujimoto M, Kadono T, Sato S, Abe M, Ohhara K, Takehara K.
    Biochem Biophys Res Commun; 1993 Oct 15; 196(1):409-415. PubMed ID: 8216321
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
    Pietras K, Rubin K, Sjöblom T, Buchdunger E, Sjöquist M, Heldin CH, Ostman A.
    Cancer Res; 2002 Oct 01; 62(19):5476-84. PubMed ID: 12359756
    [Abstract] [Full Text] [Related]

  • 7. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L, Maire G, Pedeutour F, Groupe Francophone de Cytogénétique Oncologique.
    Bull Cancer; 2007 Feb 01; 94(2):179-89. PubMed ID: 17337387
    [Abstract] [Full Text] [Related]

  • 8. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA.
    J Clin Oncol; 2005 Feb 01; 23(4):866-73. PubMed ID: 15681532
    [Abstract] [Full Text] [Related]

  • 9. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
    O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP.
    Genes Chromosomes Cancer; 1998 Oct 01; 23(2):187-93. PubMed ID: 9739023
    [Abstract] [Full Text] [Related]

  • 10. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 11. Dermatofibrosarcoma protuberans: recent clinical progress.
    McArthur G.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2876-86. PubMed ID: 17647063
    [Abstract] [Full Text] [Related]

  • 12. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
    Sirvent N, Maire G, Pedeutour F.
    Genes Chromosomes Cancer; 2003 May 01; 37(1):1-19. PubMed ID: 12661001
    [Abstract] [Full Text] [Related]

  • 13. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
    Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR.
    Int J Cancer; 2002 Aug 20; 100(6):623-6. PubMed ID: 12209598
    [Abstract] [Full Text] [Related]

  • 14. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B, Sanmartín O, López-Guerrero JA, Monteagudo C, Serra C, Requena C, Poveda A, Vistós JL, Almenar S, Llombart-Bosch A, Guillén C.
    Histopathology; 2009 Jun 20; 54(7):860-72. PubMed ID: 19635106
    [Abstract] [Full Text] [Related]

  • 15. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
    Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM.
    Pediatr Blood Cancer; 2010 Aug 20; 55(2):369-73. PubMed ID: 20582941
    [Abstract] [Full Text] [Related]

  • 16. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G, Timeus F, Rinaldi A, Crescenzio N, Spinelli M, Rosolen A, Ricotti E, Basso G.
    Int J Mol Med; 2004 Sep 20; 14(3):373-82. PubMed ID: 15289888
    [Abstract] [Full Text] [Related]

  • 17. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
    Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Buchdunger E, Black PM, Stiles CD.
    Cancer Res; 2000 Sep 15; 60(18):5143-50. PubMed ID: 11016641
    [Abstract] [Full Text] [Related]

  • 18. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D.
    Hum Pathol; 2008 Feb 15; 39(2):184-93. PubMed ID: 17950782
    [Abstract] [Full Text] [Related]

  • 19. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G, Lin SN, Asagoe K, Suzuki N, Matsuo A, Tanaka R, Makino E, Fujimoto W, Iwatsuki K.
    Eur J Dermatol; 2007 Feb 15; 17(3):217-9. PubMed ID: 17478383
    [Abstract] [Full Text] [Related]

  • 20. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
    Goldblum JR.
    Arch Pathol Lab Med; 1996 Nov 15; 120(11):1052-5. PubMed ID: 12049108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.